Product Name: Human CD39 Antibody (TTX-030, Research Use)
Catalog Number: NBR-0131
Target Name: CD39
Trade Name: TTX-030
Antibody Drug Description: TTX-030 is a first-in-class antibody that inhibits the activity of CD39. TTX-030 targets the ATP-adenosine pathway and inhibition of CD39 is believed to modulate immune suppression within the tumor microenvironment, thus increasing anti-tumor immunity. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD39
Synonyms: ENTPD1; NTPDase-1; ATPDase; SPG64
Target Description: ENTPD1 (Ectonucleoside Triphosphate Diphosphohydrolase 1) is a Protein Coding gene. Diseases associated with ENTPD1 include Spastic Paraplegia 64, Autosomal Recessive and Thrombosis. Among its related pathways are Metabolism of nucleotides and Disease. Gene Ontology (GO) annotations related to this gene include hydrolase activity and nucleoside diphosphate phosphatase activity. An important paralog of this gene is ENTPD8.
Ensembl: ENSG00000138185
Uniprot: P49961